DiaMedica Therapeutics(DMAC) - 2024 Q2 - Earnings Call Transcript

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q2 2024 Earnings Conference Call August 8, 2024 8:00 AM ET Company Participants Rick Pauls - President, Chief Executive Officer & Director Lorianne Masuoka - Chief Medical Officer Scott Kellen - Chief Financial Officer & Company Secretary Conference Call Participants Thomas Flaten - Lake Street Operator Good morning ladies and gentlemen and welcome to the DiaMedica Therapeutics Second Quarter 2024 Conference Call. An audio recording of the webcast will be available ...